A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
Searching for the fountain of eternal youth has been the dream of humanity for millennia.…
The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma…
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood…
There is a lot of talk about how cell and gene therapy are going to…
European companies developing advanced therapies such as gene and cell therapies secured at least €2.2B…
While there are now more cell therapies on offer than ever before, there are obstacles…
UK biotech startup Bit Bio has received €36.9M in Series A funding to boost the…
The Bordeaux-based company Treefrog Therapeutics has opened an industrial demonstration plant with the aim of…
The excessive inflammatory response seen in the most serious cases of Covid-19, along with shortages…
Israeli cell therapy biotech Pluristem Therapeutics has secured up to €50M in non-dilutive funding from…
The UK company MicrofluidX has closed a €1.6M (£1.4 M) seed funding round to develop…